Reducing preterm birth risks in foetal surgery, KOVE Medical secures €1.7 million
Zurich-based MedTech startup KOVE Medical has closed a €1.7 million (CHF 1.6 million) to develop an implantable medical device designed to reduce the risk of preterm birth following foetal surgery, with the fresh capital set to support the company as it progresses towards First-in-Human studies. The round was backed by a syndicate of angel investors. […] The post Reducing preterm birth risks in…
We haven't written up this one. EU-Startups has the full story — the link below goes straight to it.
